Coordinate activation of intracellular signaling pathways by insulin-like growth factor-1 and platelet-derived growth factor in rat hepatic stellate cells

Journal of Laboratory and Clinical Medicine

Volumn 147, Issue 5, 2006, Pages 234-241

  Bridle, Kim R ^a   Li, Lin ^a   O'Neill, Rosemary ^a   Britton, Robert S ^a   Bacon, Bruce R ^a  

^a Saint Louis University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PLATELET DERIVED GROWTH FACTOR; S6 KINASE; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; FIBROGENESIS; LIVER CELL; MITOGENESIS; NONHUMAN; PROTEIN FUNCTION; RAT; SIGNAL TRANSDUCTION; STELLATE CELL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CELL PROLIFERATION; CELLS, CULTURED; CYCLIN D1; DRUG COMBINATIONS; ENZYME INHIBITORS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GLYCOGEN SYNTHASE KINASE 3; INSULIN-LIKE GROWTH FACTOR I; KUPFFER CELLS; MALE; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION;

EID: 33646375417     PISSN: 00222143     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lab.2005.12.009     Document Type: Article

References (70)

1. Pinzani M., Gesualdo L., Sabbah G.M., and Abboud H.E. Effects of platelet-derived growth factor and other polypeptide mitogens on DNA synthesis and growth of cultured rat liver fat-storing cells. J Clin Invest 84 (1989) 1786-1793
2. Friedman S.L. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 328 (1993) 1828-1835
3. Hui A.Y., and Friedman S.L. Molecular basis of hepatic fibrosis. Expert Rev Mol Med 2003 (2003) 1-23
4. Gressner A.M. Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts. a key event in hepatic fibrogenesis. Kidney Int Suppl 54 (1996) S39-S45
5. Pinzani M., and Marra F. Cytokine receptors and signaling in hepatic stellate cells. Semin Liver Dis 21 (2001) 397-416
6. Scharf J.G., Knittel T., Dombrowski F., Muller L., Saile B., Braulke T., et al. Characterization of the IGF axis components in isolated rat hepatic stellate cells. Hepatology 27 (1998) 1275-1284
7. Svegliati-Baroni G., Ridolfi F., Di Sario A., Casini A., Marucci L., Gaggiotti G., et al. Insulin and insulin-like growth factor-1 stimulate proliferation and type 1 collagen accumulation by hepatic stellate cells. differential effects on signal transduction pathways. Hepatology 29 (1999) 1743-1751
8. Froesch E.R., Schmid C., Schwander J., and Zapf J. Actions of insulin-like growth factors. Annu Rev Physiol 47 (1985) 443-467
9. Novosyadlyy R., Tron K., Dudas J., Ramadori G., and Scharf J.G. Expression and regulation of the insulin-like growth factor axis components in rat liver myofibroblasts. J Cell Physiol 199 (2004) 388-398
10. Sanz S., Pucilowska J.B., Liu S., Rodriguez-Ortigosa C.M., Lund P.K., Brenner D.A., et al. Expression of insulin-like growth factor I by activated hepatic stellate cells reduces fibrogenesis and enhances regeneration after liver injury. Gut 54 (2005) 134-141
11. Marra F., Pinzani M., DeFranco R., Laffi G., and Gentilini P. Involvement of phosphatidylinositol 3-kinase in the activation of extracellular signal-regulated kinase by PDGF in hepatic stellate cells. FEBS Lett 376 (1995) 141-145
12. Marra F., Gentilini A., Pinzani M., Choudhury G.G., Parola M., Herbst H., et al. Phosphatidylinositol 3-kinase is required for platelet-derived growth factor's actions on hepatic stellate cells. Gastroenterology 112 (1997) 1297-1306
13. Marra F., Arrighi M.C., Fazi M., Caligiuri A., Pinzani M., Romanelli R.G., et al. Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by in vivo liver injury in the rat. Hepatology 30 (1999) 951-958
14. Skrtic S., Wallenius K., Gressner A.M., and Jansson J.-O. Insulin-like growth factor signaling pathways in rat hepatic stellate cells. importance for deoxyribonucleic acid synthesis and hepatocyte growth factor production. Endocrinology 140 (1999) 5729-5735
15. Gentilini A., Marra F., Gentilini P., and Pinzani M. Phosphatidylinositol-3 kinase and extracellular signal-regulated kinase mediate the chemotactic and mitogenic effects of insulin-like growth factor-1 in human hepatic stellate cells. J Hepatol 32 (2000) 227-234
16. Marais R., and Marshall C.J. Control of the ERK MAP kinase cascade by Ras and Raf. Cancer Surv 27 (1996) 101-125
17. Su B., and Karin M. Mitogen-activated protein kinase cascades and regulation of gene expression. Curr Opin Immunol 8 (1996) 402-411
18. Britton R.S., and Bacon B.R. Intracellular signaling pathways in stellate cell activation. Alcohol Clin Exp Res 23 (1999) 922-925
19. Pages G., Lenormand P., L'Allemain G., Chambard J.C., Meloche S., and Pouyssegur J. Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. Proc Natl Acad Sci USA 90 (1993) 8319-8323
20. Weber J.D., Raben D.M., Phillips P.J., and Baldassare J.J. Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J 326 (1997) 61-68
21. Weber J.D., Hu W., Jefcoat Jr. S.C., Raben D.M., and Baldassare J.J. Ras-stimulated extracellular signal-related kinase 1 and RhoA activities coordinate platelet-derived growth factor-induced G1 progression through the independent regulation of cyclin D1 and p27. J Biol Chem 272 (1997) 32966-32971
22. Pawson T. Protein modules and signalling networks. Nature 373 (1995) 573-580
23. Cohen G.B., Ren R., and Baltimore D. Modular binding domains in signal transduction proteins. Cell 80 (1995) 237-248
24. Duronio V., Scheid M.P., and Ettinger S. Downstream signalling events regulated by phosphatidylinositol 3-kinase activity. Cellular Signal 10 (1998) 233-239
25. Shepherd P.R., Withers D.J., and Siddle K. Phosphoinositide 3-kinase. the key switch mechanism in insulin signalling. Biochem J 333 (1998) 471-490
26. Leevers S.J., Vanhaesebroeck B., and Waterfield M.D. Signalling through phosphoinositide 3-kinases. the lipids take centre stage. Curr Opin Cell Biol 11 (1999) 219-225
27. Rameh L.E., and Cantley L.C. The role of phosphoinositide 3-kinase lipid products in cell function. J Biol Chem 274 (1999) 8347-8350
28. Fruman D.A., Meyers R.E., and Cantley L.C. Phosphoinositide kinases. Ann Rev Biochem 67 (1998) 481-507
29. Fukui Y., Ihara S., and Nagata S. Downstream of phosphatidylinositol-3 kinase, a multifunctional signaling molecule, and its regulation in cell responses. J Biochem 124 (1998) 1-7
30. Minshall C., Arkins S., Dantzer R., Freund G.G., and Kelley K.W. Phosphatidylinositol 3'-kinase, but not S6-kinase, is required for insulin-like growth factor-I and IL-4 to maintain expression of Bcl-2 and promote survival of myeloid progenitors. J Immunol 162 (1999) 4542-4549
31. Vanhaesebroeck B., and Waterfield M.D. Signaling by distinct classes of phosphoinositide 3-kinases. Exp Cell Res 253 (1999) 239-254
32. Coffer P.J., Jin J., and Woodgett J.R. Protein kinase B (c-Akt). a multifunctional mediator of phosphatidylinositol 3-kinase activation. Biochem J 335 (1998) 1-13
33. Alessi D.R., and Cohen P. Mechanism of activation and function of protein kinase B. Curr Opin Genet Dev 8 (1998) 55-62
34. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 10 (1998) 262-267
35. Kandel E.S., and Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 253 (1999) 210-229
36. Hong F., Kwon S.J., Jhun B.S., Kim S.S., Ha J., Kim S.J., et al. Insulin-like growth factor-1 protects H9c2 cardiac myoblasts from oxidative stress-induced apoptosis via phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways. Life Sci 68 (2001) 1095-1105
37. Koulich E., Nguyen T., Johnson K., Giardina C.A., and D'Mello S.R. NF-kappaB is involved in the survival of cerebellar granule neurons. association of Ikappabeta phosphorylation with cell survival. J Neurochem 76 (2001) 1188-1198
38. Pirianov G., and Colston K.W. Interaction of vitamin D analogs with signaling pathways leading to active cell death in breast cancer cells. Steroids 66 (2001) 309-318
39. Withers D.J., Seufferlein T., Mann D., Garcia B., Jones N., and Rozengurt E. Rapamycin dissociates p70(S6K) activation from DNA synthesis stimulated by bombesin and insulin in Swiss 3T3 cells. J Biol Chem 272 (1997) 2509-2514
40. Chou M.M., and Blenis J. The 70 kDa S6 kinase. regulation of a kinase with multiple roles in mitogenic signalling. Curr Opin Cell Biol 7 (1995) 806-814
41. Proud C.G. p70 S6 kinase. an enigma with variations. Trends Biochem Sci 21 (1996) 181-185
42. Abraham R.T. Mammalian target of rapamycin. immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling. Curr Opin Immunol 10 (1998) 330-336
43. Sehgal S.N. Rapamune (RAPA, rapamycin, sirolimus). mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression. Clin Biochem 31 (1998) 335-340
44. Ferrari S., and Thomas G. S6 phosphorylation and the p70s6k/p85s6k. Crit Rev Biochem Mol Biol 29 (1994) 385-413
45. Nourse J., Firpo E., Flanagan W.M., Coats S., Polyak K., Lee M.H., et al. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372 (1994) 570-573
46. Lania L., Majello B., and Napolitano G. Transcriptional control by cell-cycle regulators. a review. J Cell Physiol 179 (1999) 134-141
47. Pavletich N.P. Mechanisms of cyclin-dependent kinase regulation. structures of Cdks, their cyclin activators, and Cip and INK4 inhibitors. J Mol Biol 287 (1999) 821-828
48. Sherr C.J. G1 phase progression. cycling on cue. Cell 79 (1994) 551-555
49. Morgan D.O. Principles of CDK regulation. Nature 374 (1995) 131-134
50. Ohtsubo M., Theodoras A.M., Schumacher J., Roberts J.M., and Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol Cell Biol 15 (1995) 2612-2624
51. Friedman S.L., and Roll F.J. Isolation and culture of hepatic lipocytes, Kupffer cells, and sinusoidal endothelial cells by density gradient centrifugation with Stractan. Anal Biochem 161 (1987) 207-218
52. Ramm G.A., Britton R.S., O'Neill R., and Bacon B.R. Identification and characterization of a receptor for tissue ferritin on activated rat lipocytes. J Clin Invest 94 (1994) 9-15
53. Ramm G.A., Britton R.S., O'Neill R., Kohn H.D., and Bacon B.R. Rat liver ferritin selectively inhibits expression of alpha-smooth muscle actin in cultured rat lipocytes. Am J Physiol 270 (1996) G370-G375
54. Davis B.H., and Kresina T.F. Hepatic fibrogenesis. Clin Lab Med 16 (1996) 361-375
55. Pinzani M., Knauss T.C., Pierce G.F., Hsieh P., Kenney W., Dubyak G.R., et al. Mitogenic signals for platelet-derived growth factor isoforms in liver fat-storing cells. Am J Physiol 260 (1991) C485-C491
56. Pinzani M., Milani S., Grappone C., Weber Jr. F.L., Gentilini P., and Abboud H.E. Expression of platelet-derived growth factor in a model of acute liver injury. Hepatology 19 (1994) 701-707
57. Wong L., Yamasaki G., Johnson R.J., and Friedman S.L. Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J Clin Invest 94 (1994) 1563-1569
58. Pinzani M., Gentilini A., Caligiuri A., De Franco R., Pellegrini G., Milani S., et al. Transforming growth factor-beta 1 regulates platelet-derived growth factor receptor beta subunit in human liver fat-storing cells. Hepatology 21 (1995) 232-239
59. Davis B.H., Coll D., and Beno D.W. Retinoic acid suppresses the response to platelet-derived growth factor in human hepatic Ito-cell-like myofibroblasts. a post-receptor mechanism independent of raf/fos/jun/egr activation. Biochem J 294 (1993) 785-791
60. Zhu J., Wu J., Frizell E., Liu S.L., Bashey R., Rubin R., et al. Rapamycin inhibits hepatic stellate cell proliferation in vitro and limits fibrogenesis in an in vivo model of liver fibrosis. Gastroenterology 117 (1999) 1198-1204
61. Brenzel A., and Gressner A.M. Characterization of insulin-like growth factor (IGF)-I-receptor binding sites during in vitro transformation of rat hepatic stellate cells to myofibroblasts. Eur J Clin Chem Clin Biochem 34 (1996) 401-409
62. Hoffmann C., Lahme B., Brenzel A., and Gressner A.M. The relation between hepatocellular damage and activation of fat-storing cell proliferation in vitro. Int Hepatol Comm 22 (1994) 1507-1518
63. Gressner A.M., Lahme B., and Brenzel A. Molecular dissection of the mitogenic effect of hepatocytes on cultured hepatic stellate cells. Hepatology 22 (1995) 1507-1518
64. Pinzani M., Abboud H.E., and Aron D.C. Secretion of insulin-like growth factor-I and binding proteins by rat liver fat-storing cells. regulatory role of platelet-derived growth factor. Endocrinology 127 (1990) 2343-2349
65. Gressner A.M., Brenzel A., and Vossmeyer T. Hepatocyte-conditioned medium potentiates insulin-like growth factor (IGF) 1 and 2 stimulated DNA synthesis of cultured fat storing cells. Liver 13 (1993) 86-94
66. Kuemmerle J.F., and Bushman T.L. IGF-I stimulates intestinal muscle cell growth by activating distinct PI 3-kinase and MAP kinase pathways. Am J Physiol 275 (1998) G151-G158
67. Gäbele E., Reif S., Tsukada S., Bataller R., Yata Y., Morris T., et al. The role of p70S6K in hepatic stellate cell collagen gene expression and cell proliferation. J Biol Chem 280 (2005) 13374-13382
68. Kawada N., Seki S., Inoue M., and Kuroki T. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells. Hepatology 27 (1998) 1265-1274
69. Kawada N., Ikeda K., Seki S., and Kuroki T. Expression of cyclins D1, D2 and E correlates with proliferation of rat stellate cells in culture. J Hepatol 30 (1999) 1057-1064
70. Issa R., Williams E., Trim N., Kendall T., Arthur M.J.P., Reichen J., et al. Apoptosis of hepatic stellate cells. involvement in resolution of biliary fibrosis and regulation by soluble growth factors. Gut 48 (2001) 548-557